Free Trial

Boston Scientific (BSX) Competitors

Boston Scientific logo
$99.60 +1.04 (+1.06%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$99.28 -0.32 (-0.32%)
As of 06/13/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BSX vs. ABT, ISRG, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STE

Should you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.

Boston Scientific vs. Its Competitors

Boston Scientific (NYSE:BSX) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, community ranking, earnings and media sentiment.

Boston Scientific currently has a consensus target price of $116.00, suggesting a potential upside of 16.47%. Abbott Laboratories has a consensus target price of $142.59, suggesting a potential upside of 5.30%. Given Boston Scientific's stronger consensus rating and higher possible upside, equities analysts plainly believe Boston Scientific is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Boston Scientific
0 Sell rating(s)
0 Hold rating(s)
20 Buy rating(s)
2 Strong Buy rating(s)
3.09
Abbott Laboratories
0 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.84

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.5% of Boston Scientific shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Boston Scientific has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.

In the previous week, Abbott Laboratories had 26 more articles in the media than Boston Scientific. MarketBeat recorded 65 mentions for Abbott Laboratories and 39 mentions for Boston Scientific. Abbott Laboratories' average media sentiment score of 1.17 beat Boston Scientific's score of 1.10 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Boston Scientific
28 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Abbott Laboratories
50 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive

Abbott Laboratories has a net margin of 31.95% compared to Boston Scientific's net margin of 11.07%. Abbott Laboratories' return on equity of 20.74% beat Boston Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Boston Scientific11.07% 17.80% 9.85%
Abbott Laboratories 31.95%20.74%11.19%

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Abbott Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boston Scientific$17.55B8.39$1.85B$1.3772.70
Abbott Laboratories$42.34B5.56$13.40B$7.7117.56

Boston Scientific received 118 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 70.00% of users gave Abbott Laboratories an outperform vote while only 69.98% of users gave Boston Scientific an outperform vote.

CompanyUnderperformOutperform
Boston ScientificOutperform Votes
1070
69.98%
Underperform Votes
459
30.02%
Abbott LaboratoriesOutperform Votes
952
70.00%
Underperform Votes
408
30.00%

Summary

Abbott Laboratories beats Boston Scientific on 10 of the 19 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSX vs. The Competition

MetricBoston ScientificSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$147.35B$4.32B$5.57B$19.68B
Dividend YieldN/A42.67%5.27%3.80%
P/E Ratio79.6828.6426.7534.98
Price / Sales8.3968.00403.9842.66
Price / Cash28.8651.0838.2517.51
Price / Book6.685.746.964.78
Net Income$1.85B$66.95M$3.23B$1.02B
7 Day Performance-2.39%-3.05%-1.22%0.82%
1 Month Performance-4.81%0.71%6.34%1.32%
1 Year Performance29.76%18.95%33.05%10.65%

Boston Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BSX
Boston Scientific
4.5737 of 5 stars
$99.60
+1.1%
$116.00
+16.5%
+29.8%$147.35B$17.55B79.6845,000Positive News
ABT
Abbott Laboratories
4.9287 of 5 stars
$133.41
-0.1%
$142.59
+6.9%
+30.6%$232.11B$42.34B17.44115,000Trending News
Dividend Announcement
ISRG
Intuitive Surgical
4.701 of 5 stars
$525.98
-5.6%
$588.95
+12.0%
+20.3%$188.52B$8.71B82.0612,100High Trading Volume
SYK
Stryker
4.9105 of 5 stars
$382.25
-0.4%
$427.30
+11.8%
+9.3%$145.90B$23.22B49.2651,000Positive News
Analyst Upgrade
MDT
Medtronic
4.8952 of 5 stars
$87.46
+0.0%
$97.00
+10.9%
+7.6%$112.18B$33.54B26.5895,000Trending News
Short Interest ↓
BDX
Becton, Dickinson and Company
4.9534 of 5 stars
$172.47
+0.0%
$219.22
+27.1%
-26.4%$49.43B$20.87B28.6577,000Positive News
Options Volume
EW
Edwards Lifesciences
4.5619 of 5 stars
$76.35
-1.5%
$80.20
+5.0%
-13.9%$44.79B$5.52B10.9517,300Positive News
IDXX
IDEXX Laboratories
3.7822 of 5 stars
$518.74
-1.2%
$536.00
+3.3%
+3.7%$41.72B$3.93B48.6210,800News Coverage
Positive News
Analyst Forecast
RMD
ResMed
4.0339 of 5 stars
$251.02
-0.5%
$259.33
+3.3%
+17.7%$36.81B$5.02B29.648,160Positive News
Insider Trade
DXCM
DexCom
4.7453 of 5 stars
$85.65
-1.2%
$98.32
+14.8%
-29.3%$33.58B$4.15B59.907,600
STE
STERIS
4.559 of 5 stars
$242.67
-0.4%
$263.83
+8.7%
+10.5%$23.87B$5.46B51.5216,000Ex-Dividend
Analyst Upgrade
Analyst Revision

Related Companies and Tools


This page (NYSE:BSX) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners